Skip Navigation

Accreditations, Affiliations, and Leadership

  • Clinicians at Dana-Farber/Brigham and Women's Cancer Center's Hematologic Malignancies Program hold presidency and leadership roles in national organizations, provide editorial oversight of influential journals, and are teachers in the field.

    Some of our affiliations and accreditations include:


    • Key member of the Alliance for Clinical Trials in Oncology's Multiple Myeloma Committee
    • Founding institution of the Multiple Myeloma Research Consortium (MMRC)
    • Longstanding full member of the Center for International Blood and Marrow Transplant Research (CIBMTR), serving on working committees and the Executive Committee
    • Fully accredited by the National Marrow Donor Program (NMDP)
    • Member of the Cancer and Leukemia Group B (CALGB)
    • Accredited by the Foundation for the Accreditation of Cellular Therapy (FACT)
    • Charter Member of the Blood and Marrow Transplant Clinical Trials Network of the National Institutes of Health
    • Accredited by Center for Medicare and Medicaid Services (CMS) Clinical Laboratory Improvement Amendment (CLIA)
    • Our HM/HSCT staff includes more than 30 physicians and 20 nurses, plus approximately 20 mid-level practitioners.


    • Awarded Magnet® designation by American Nurses Credentialing Center
    • Disease Attacking the Immune System (DAISY) Foundation award participant


    • Teaching affiliate of Harvard Medical School
    • Member of Dana-Farber/Harvard Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center
    • Responsible for oversight of the National Comprehensive Cancer Network (NCCN) clinical practice guidelines
    • Food and Drug Administration (FDA)-registered
    • Joint Commission Hospital accreditation
    • Joint Commission Laboratory accreditation
    • Quality Oncology Practice Initiative (QOPI)-certified
    • Staff participation includes:
      • Past presidents and current treasurer of American Society for Bone Marrow Transplant (ASBMT)
      • Current vice president of American Society of Hematology (ASH) Executive Committee
      • Current member of Lymphoma Research Foundation (LRF) Scientific Advisory Board
      • Current member of Board of Scientific Advisors of the National Cancer Institute (NCI)